No black box warning on record for Iopamidol

As of the latest FDA labeling reviewed, Iopamidol (IOPAMIDOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Iopamidol medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS The need for myelographic examination should be carefully evaluated. Iopamidol should be administered with caution in patients with increased intracranial pressure or suspicion of intracranial tumor, abscess or hematoma, those with a history of convulsive disorder, severe cardiovascular disease, chronic alcoholism, or multiple sclerosis, and elderly patients. Particular attention must be

No black box warning on record for Iopamidol

Other warnings & precautions

WARNINGS The need for myelographic examination should be carefully evaluated. Iopamidol should be administered with caution in patients with increased intracranial pressure or suspicion of intracranial tumor, abscess or hematoma, those with a history of convulsive disorder, severe cardiovascular disease, chronic alcoholism, or multiple sclerosis, and elderly patients. Particular attention must be

Iopamidol Black Box Warning

No black box warning on record for Iopamidol

Other warnings & precautions

Iopamidol Black Box Warning

No black box warning on record for Iopamidol

Other warnings & precautions